We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.
Treatments

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What Is Icatibant?

By Karize Uy
Updated: May 17, 2024
Views: 7,425
References
Share

Icatibant is a type of medication used to treat hereditary angioedema (HAE), a medical condition that causes the layers of the skin to become swollen and reddish in appearance, usually located around the mouth and the eyes. In a nutshell, the drug prevents the blood vessels from dilating and carrying more blood and other fluids, which causes the swelling in a particular area. As of July 2008, icatibant has been approved as the treatment for HAE by the European Commission and has been classified as an “orphan drug,” which means that the drug was created as a treatment for a specific medical condition. In August 2011, the US Food and Drug Administration (FDA) also gave its approval for the drug, but prohibited the use of the drug on patients younger than 18 years.

Various research has shown that the interaction between the peptide “bradykinin” and the B2 receptor as the primary cause for HAE. These two molecules act like a lock and key; when the bradykinin is “slot in” the b2 receptor, this triggers the dilation of blood vessels. In the case of HAE, there is an excessive amount of bradykinin, causing blood vessels to expand and the blood, along with other bodily fluids, to rush to an area and make it swollen and usually painful. What icatibant does is it inhibits the action of the bradykinins and prevents them from binding to the receptors, greatly reducing the symptoms of HAE.

As a drug, icatibant is said to be “peptidomimetic,” a drug that mimics the function of certain peptides. The drug contains ten amino acids that act as antagonists for the b2 receptors. It is usually introduced to the patient via injection in the stomach area. A single-use syringe is usually filled with a 3mL solution, containing 30mg of icatibant. If HAE symptoms persist or are not reduced, another injection can be administered after at least six hours.

Some side effects of icatibant include nausea, drowsiness, and fatigue, which is why patients under treatment are advised not to drive, handle heavy machines, or undergo any activity that requires alertness. Patients who have sensitive skin may also experience some rashes, itchiness, or numbness in the area where the icatibant solution is injected. Patients can only have a maximum of three doses in a day, since overdosing can cause a patient to experience extremely low blood pressure, itching, and severe redness of skin. Before taking the treatment, female patients should also inform their physicians if they are breastfeeding, pregnant, or have other health conditions.

Share
WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Link to Sources

Editors' Picks

Discussion Comments
Share
https://www.wisegeek.net/what-is-icatibant.htm
Copy this link
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.